WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect - the Danish experience

被引:4
作者
Madelung, Ann B. [1 ]
Bondo, Henrik [1 ]
Stamp, Inger [1 ]
Lovgreen, Preben [2 ]
Nielsen, Signe L. [3 ]
Falensteen, Anne [3 ]
Knudsen, Helle [3 ]
Svendsen, Kira D. [4 ]
Lange, Theis [4 ]
Ralfkiaer, Elisabeth [5 ]
Nielsen, Karsten [1 ]
Hasselbalch, Hans [6 ]
Thiele, Juergen [7 ]
机构
[1] Naestved & Slagelse Hosp, Dept Pathol, DK-4700 Naestved, Denmark
[2] Roskilde & Koge Hosp, Dept Pathol, Roskilde, Denmark
[3] Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark
[4] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Dept Pathol, Copenhagen, Denmark
[6] Roskilde & Koge Hosp, Dept Haematol, Roskilde, Denmark
[7] Univ Cologne, Inst Pathol, Cologne, Germany
关键词
Learning effect; interobserver agreement; myeloproliferative neoplasms; workshop; multiheaded microscope; WORLD-HEALTH-ORGANIZATION; BONE-MARROW FIBROSIS; ESSENTIAL THROMBOCYTHEMIA; PRIMARY MYELOFIBROSIS; EUROPEAN CONSENSUS; DIAGNOSIS; RUXOLITINIB; PATHOLOGY; SURVIVAL; CRITERIA;
D O I
10.1111/apm.12417
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the learning effect of a workshop for Danish hematopathologists led by an international expert regarding histological subtyping of myeloproliferative neoplasms (MPN). Six hematopathologists evaluated 43 bone marrow (BM) biopsies according to the WHO description (2008), blinded to clinical data. All panelists then participated in the workshop. The case biopsies - mixed with 251 other MPN BM biopsies - were reviewed again. Consensus regarding the histological subtype was significantly improved; from 49% to 72% (Fleiss kappa value 0.302 pre-workshop, 0.474 post-workshop; p=0.004). There was no significant effect on the isolated morphological characteristics. Agreement between cases with histological consensus and clinical diagnosis was 86% without significant change during workshop sessions. Our study demonstrates that experienced hematopathologists can significantly improve their diagnostic ability by a workshop led by an international expert; not by improving the evaluation of individual histological parameters but by weighting these in their conclusive diagnosis.
引用
收藏
页码:787 / 792
页数:6
相关论文
共 25 条
[1]   The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera [J].
Abdulkarim, Khadija ;
Ridell, Borje ;
Johansson, Peter ;
Kutti, Jack ;
Safai-Kutti, Soodabeh ;
Andreasson, Bjorn .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (02) :148-155
[2]   Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia [J].
Barbui, T. ;
Thiele, J. ;
Vannucchi, A. M. ;
Tefferi, A. .
LEUKEMIA, 2013, 27 (10) :1953-1958
[3]   Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study [J].
Barbui, Tiziano ;
Thiele, Juergen ;
Passamonti, Francesco ;
Rumi, Elisa ;
Boveri, Emanuela ;
Ruggeri, Marco ;
Rodeghiero, Francesco ;
d'Amore, Emanuele S. G. ;
Randi, Maria Luigia ;
Bertozzi, Irene ;
Marino, Filippo ;
Vannucchi, Alessandro M. ;
Antonioli, Elisabetta ;
Carrai, Valentina ;
Gisslinger, Heinz ;
Buxhofer-Ausch, Veronika ;
Muellauer, Leonhard ;
Carobbio, Alessandra ;
Gianatti, Andrea ;
Gangat, Naseema ;
Hanson, Curtis A. ;
Tefferi, Ayalew .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (23) :3179-3184
[4]   The Danish Pathology Register [J].
Bjerregaard, Beth ;
Larsen, Ole B. .
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2011, 39 :72-74
[5]   Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis [J].
Brousseau, Maud ;
Parot-Schinkel, Elsa ;
Moles, Marie-Pierre ;
Boyer, Francoise ;
Hunault, Mathilde ;
Rousselet, Marie-Christine .
HISTOPATHOLOGY, 2010, 56 (06) :758-767
[6]   European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis [J].
Buhr, Thomas ;
Hebeda, Konnie ;
Kaloutsi, Vassiliki ;
Porwit, Anna ;
Van der Walt, Jon ;
Kreipe, Hans .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03) :360-365
[7]   The Role of Pathology Experts in Defining Practice Gaps in Continuing Pathology Education: What Do We Need to Know and How Can We Find Them? [J].
Calkins, Sarah ;
Silva, Fred ;
Tihan, Tarik .
ADVANCES IN ANATOMIC PATHOLOGY, 2012, 19 (03) :187-190
[8]   Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up [J].
Ejerblad, Elisabeth ;
Kvasnicka, Hans M. ;
Thiele, Juergen ;
Andreasson, Bjorn ;
Bjorkholm, Magnus ;
Lofvenberg, Eva ;
Markevarn, Berit ;
Merup, Mats ;
Nilssson, Lars ;
Palmblad, Jan ;
Samuelsson, Jan ;
Birgegard, Gunnar .
HEMATOLOGY, 2013, 18 (01) :8-13
[9]   The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis [J].
Gianelli, Umberto ;
Vener, Claudia ;
Bossi, Anna ;
Cortinovis, Ivan ;
Iurlo, Alessandra ;
Fracchiolla, Nicola S. ;
Savi, Federica ;
Moro, Alessia ;
Grifoni, Federica ;
De Philippis, Chiara ;
Radice, Tommaso ;
Bosari, Silvano ;
Deliliers, Giorgio Lambertenghi ;
Cortelezzi, Agostino .
MODERN PATHOLOGY, 2012, 25 (09) :1193-1202
[10]   JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis [J].
Harrison, Claire ;
Kiladjian, Jean-Jacques ;
Al-Ali, Haifa Kathrin ;
Gisslinger, Heinz ;
Waltzman, Roger ;
Stalbovskaya, Viktoriya ;
McQuitty, Mari ;
Hunter, Deborah S. ;
Levy, Richard ;
Knoops, Laurent ;
Cervantes, Francisco ;
Vannucchi, Alessandro M. ;
Barbui, Tiziano ;
Barosi, Giovanni .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :787-798